White DE - Search Results

1

Vitiligo in patients with melanoma: normal tissue antigens can be targets for cancer immunotherapy.

Rosenberg SA, White DE. Rosenberg SA, et al. Among authors: white de. J Immunother Emphasis Tumor Immunol. 1996 Jan;19(1):81-4. J Immunother Emphasis Tumor Immunol. 1996. PMID: 8859727

2

Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.

Sanda MG, Yang JC, Topalian SL, Groves ES, Childs A, Belfort R Jr, de Smet MD, Schwartzentruber DJ, White DE, Lotze MT, et al. Sanda MG, et al. Among authors: de smet md, white de. J Clin Oncol. 1992 Oct;10(10):1643-9. doi: 10.1200/JCO.1992.10.10.1643. J Clin Oncol. 1992. PMID: 1403042 Clinical Trial.

3

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Marincola FM, Venzon D, White D, Rubin JT, Lotze MT, Simonis TB, Balkissoon J, Rosenberg SA, Parkinson DR. Marincola FM, et al. Cancer Res. 1992 Dec 1;52(23):6561-6. Cancer Res. 1992. PMID: 1423301

4

The use of interleukin-2 and lymphokine-activated killer cells for the treatment of patients with non-Hodgkin's lymphoma.

Weber JS, Yang JC, Topalian SL, Schwartzentruber DJ, White DE, Rosenberg SA. Weber JS, et al. Among authors: white de. J Clin Oncol. 1992 Jan;10(1):33-40. doi: 10.1200/JCO.1992.10.1.33. J Clin Oncol. 1992. PMID: 1727923

5

Thyroid dysfunction associated with immunotherapy for patients with cancer.

Schwartzentruber DJ, White DE, Zweig MH, Weintraub BD, Rosenberg SA. Schwartzentruber DJ, et al. Among authors: white de. Cancer. 1991 Dec 1;68(11):2384-90. doi: 10.1002/1097-0142(19911201)68:11<2384::aid-cncr2820681109>3.0.co;2-a. Cancer. 1991. PMID: 1933775

6

Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma.

Stinson SF, DeLaney TF, Greenberg J, Yang JC, Lampert MH, Hicks JE, Venzon D, White DE, Rosenberg SA, Glatstein EJ. Stinson SF, et al. Among authors: white de. Int J Radiat Oncol Biol Phys. 1991 Nov;21(6):1493-9. doi: 10.1016/0360-3016(91)90324-w. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938558

7

Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients.

Fisher B, Keenan AM, Garra BS, Steinberg SM, White DE, DiBisceglie AM, Hoofnagle JH, Yolles P, Rosenberg SA, Lotze MT. Fisher B, et al. Among authors: white de. J Clin Oncol. 1989 Dec;7(12):1852-62. doi: 10.1200/JCO.1989.7.12.1852. J Clin Oncol. 1989. PMID: 2585024

8

Functional and psychosocial effects of multimodality limb-sparing therapy in patients with soft tissue sarcomas.

Chang AE, Steinberg SM, Culnane M, Lampert MH, Reggia AJ, Simpson CG, Hicks JE, White DE, Yang JJ, Glatstein E, et al. Chang AE, et al. Among authors: white de. J Clin Oncol. 1989 Sep;7(9):1217-28. doi: 10.1200/JCO.1989.7.9.1217. J Clin Oncol. 1989. PMID: 2671282 Clinical Trial.

9

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE. Rosenberg SA, et al. Among authors: white de. Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5. doi: 10.1097/00000658-198910000-00008. Ann Surg. 1989. PMID: 2679456 Free PMC article.

10

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Rosenberg SA, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S, White DE. Rosenberg SA, et al. Among authors: white de. J Clin Oncol. 1989 Dec;7(12):1863-74. doi: 10.1200/JCO.1989.7.12.1863. J Clin Oncol. 1989. PMID: 2685181 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results